Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xiuzheng Pharmaceutical Group Changchun High-tech Pharmaceutical is a key subsidiary of the Xiuzheng Pharmaceutical Group, one of China's largest private pharmaceutical conglomerates. Located in the Changchun High-tech Industrial Development Zone, the company specializes in the modernization of traditional Chinese medicine (TCM) and the production of high-quality chemical pharmaceuticals. Its extensive product portfolio covers therapeutic areas such as gastroenterology, respiratory health, and cardiovascular care, featuring several of China's most recognized over-the-counter (OTC) brands. The company operates state-of-the-art, GMP-certified manufacturing facilities and is a leader in the modernization of herbal medicine through advanced extraction and formulation technologies. As a core component of the Xiuzheng Group, it plays a vital role in providing affordable and effective healthcare solutions across the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xiu Zheng Pharmaceutical Group Changchun High-tech Pharmaceutical.